135 related articles for article (PubMed ID: 8386103)
1. Prevalence of hepatitis A antibodies in Swiss travellers.
Studer S; Joller-Jemelka HI; Steffen R; Grob PJ
Eur J Epidemiol; 1993 Jan; 9(1):50-4. PubMed ID: 8386103
[TBL] [Abstract][Full Text] [Related]
2. Changing hepatitis A epidemiology among Hong Kong Chinese adolescents: what are the implications?
Lee A; Cheng F; Lau L; Lo A; Fabb WE
Public Health; 1999 Jul; 113(4):185-8. PubMed ID: 10483081
[TBL] [Abstract][Full Text] [Related]
3. Risk of hepatitis A in travellers.
Steffen R
Vaccine; 1992; 10 Suppl 1():S69-72. PubMed ID: 1335664
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.
Vranckx R; Muylle L
Infection; 1990; 18(6):364-6. PubMed ID: 1963883
[TBL] [Abstract][Full Text] [Related]
5. [Seroepidemiologic survey of hepatitis A antibodies in the young adult Spanish population. Spanish Study Group on hepatitis A (1)].
González A; Bruguera M; Calbo Torrecillas F; Monge V; Dal-Ré R; Costa J
Med Clin (Barc); 1994 Oct; 103(12):445-8. PubMed ID: 7996891
[TBL] [Abstract][Full Text] [Related]
6. Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects.
Bienzle U; Bock HL; Meister W; Clemens R; Kruppenbacher JP
Lancet; 1993 Apr; 341(8851):1028. PubMed ID: 8096914
[No Abstract] [Full Text] [Related]
7. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
Reintjes R; Bosman A; de Zwart O
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of anti-HAV antibodies (hepatitis A virus) in 18-year-old males from the Florence area].
Calabri GB; Santini MG; Genovese F; Bambi F; Salvi G; Calabri G
Pediatr Med Chir; 1999; 21(5 Suppl):219-20. PubMed ID: 10963011
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control.
Whiteman D; McCall B; Falconer A
J Viral Hepat; 1998 Jul; 5(4):277-83. PubMed ID: 9751015
[TBL] [Abstract][Full Text] [Related]
10. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal.
Sawayama Y; Hayashi J; Ariyama I; Furusyo N; Kawasaki T; Kawasaki M; Itoh K; Acharya GP; Kashiwagi S
J Epidemiol; 1999 Nov; 9(5):350-4. PubMed ID: 10616269
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis A antibodies in southeastern Spain: a population-based study.
García-Fulgueiras A; Rodriguez T; Tormo MJ; Perez-Flores D; Chirlaque D; Navarro C
Eur J Epidemiol; 1997 Jun; 13(4):481-3. PubMed ID: 9258557
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies against hepatitis A virus among new immigrants in Israel.
Karetnyi YV; Mendelson E; Shlyakhov E; Rubinstein E; Golubev N; Levin R; Sandler M; Schreiber M; Rubinstein U; Shif I
J Med Virol; 1995 May; 46(1):61-5. PubMed ID: 7623008
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of hepatitis A antibodies in travellers at the Edmonton Travellers' Health Clinic--Alberta.
Kocuipchyk FR; Lightfoot PJ; Stout I; Devine RD
Can Commun Dis Rep; 1995 Apr; 21(8):65-71. PubMed ID: 7787817
[No Abstract] [Full Text] [Related]
14. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
Wong KH; Liu YM; Ng PS; Young BW; Lee SS
J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
[TBL] [Abstract][Full Text] [Related]
15. [The value of screening serology in anti-hepatitis A vaccination of travelers].
Landry P; Darioli R
Schweiz Med Wochenschr; 1998 Apr; 128(15):581-5. PubMed ID: 9606799
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of two strategies for preventing hepatitis A virus infection in Spanish travellers to developing countries.
Bayas JM; González A; Vilella A; San-Martín M; Bertran MJ; Adell C
Epidemiol Infect; 2001 Oct; 127(2):347-51. PubMed ID: 11693513
[TBL] [Abstract][Full Text] [Related]
17. [The prevalence of markers for the hepatitis A and B viruses in the population of Gijón between 6 and 25 years old].
Suárez A; Navascués CA; García R; Peredo B; Miguel D; Menéndez MT; Saro C; Román F
Med Clin (Barc); 1996 Apr; 106(13):491-4. PubMed ID: 8992130
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of anti-hepatitis A antibodies in an urban middle class area of Argentina: some associated factors.
López H; Zitto T; Baré P; Vidal G; Vukasovic J; Gómez R
Int J Infect Dis; 2000; 4(1):34-7. PubMed ID: 10689212
[TBL] [Abstract][Full Text] [Related]
19. A community prevalence study of antibodies to hepatitis A and E in inner-city London.
Bernal W; Smith HM; Williams R
J Med Virol; 1996 Jul; 49(3):230-4. PubMed ID: 8818970
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis A antibodies: prevalence in Saudi Arabia.
el-Hazmi MA
J Trop Med Hyg; 1989 Dec; 92(6):427-30. PubMed ID: 2558227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
